By Sheeba M. | May 26, 2026
Cannabis ETF Rebalancing Signals Shift Toward Profitable Operators
The cannabis sector’s biggest secret isn’t rescheduling or banking reform—it’s that profitability has finally arrived. And institutional money is noticing.
In the past 90 days, major ETFs tracking cannabis MSOs—including MSOS, THCX, and MJX—have quietly shifted their holdings away from high-growth, cash-burn plays toward operators with positive EBITDA margins. This isn’t accidental. It’s a recognition that the era of “growth at any cost” is over.
Why the Shift Matters
For years, cannabis ETF managers prioritized market share over profitability. Growth was the narrative. But Q1 2026 earnings data changed the conversation:
- Curaleaf (CURLF) posted adjusted EBITDA margins of 18%+ while maintaining $1.2B+ quarterly revenue
- Green Thumb (GTBIF) achieved 22% EBITDA margins with disciplined expansion
- Cresco Labs (CRLBF) demonstrated margin expansion despite wholesale price pressure
Meanwhile, operators chasing retail saturation with negative cash flows face weight—and ETF rebalancing algorithms noticed.
The Consolidation Play
This rebalancing is accelerating a broader trend: consolidation around cash-generative operators. Smaller, capital-intensive plays are becoming acquisition targets for the three leaders above.
ETF rebalancing increases the bid for EBITDA-positive stocks while reducing demand for unprofitable peers. It’s a vicious cycle for weak operators and a tailwind for the consolidators.
The math is simple: If you’re generating $150M+ in annual EBITDA while Trulieve (TCNNF) and smaller mid-caps burn cash chasing store count, ETF managers now prefer you. This preference cascades into higher valuations and easier M&A access.
What’s Next
Watch for continued rebalancing through Q2 2026. As more data confirms the profitability story, expect:
- Increased inflows to CURLF, GTBIF, and CRLBF-heavy ETFs
- Margin compression for Verano (VRNO) and Ascend (AAWH) as capital allocates elsewhere
- Acquisition activity accelerating in Q3 2026
Sources
- SEC EDGAR — MSO Q1 2026 Filings — Earnings data and EBITDA margins
- CNBC Cannabis Coverage — Recent industry trends
- Curaleaf Investor Relations — Q1 2026 earnings
Track cannabis stocks with the Weedstock Real-Time Tracker